Bill & Melinda Gates Foundation Strategic Investment Fund

Asset Manager

New York, New York, US

Description

Bill & Melinda Gates Foundation Strategic Investment Fund is an impact-first strategic investment arm of the Bill & Melinda Gates Foundation, focusing on life sciences, healthcare, agriculture, nutrition, and financial services to improve lives. Founded in 2009, it manages a $2.5 billion investment pool, with over 100 investments in 100+ countries, aiming to scale sustainable impact and catalyze markets.

Recent Transactions involving Bill & Melinda Gates Foundation Strategic Investment Fund

Deal	Target	Platform	Buyer	Industry
QIA invests in Ensoma, a genomic medicines company	Ensoma		Bill & Melinda Gates Foundation Strategic Investment Fund Arix Bioscience Solasta Ventures F-Prime Capital Takeda Ventures SymBiosis Alexandria Venture Investments Fred Hutchinson Cancer Center Qatar Investment Authority Catalio Capital Management Mirae Asset Financial Group Cormorant Asset Management Viking Global Investors	Genomic Medicines

Deal

Target

Platform

Buyer

Industry

QIA invests in Ensoma, a genomic medicines company

Ensoma

Bill & Melinda Gates Foundation Strategic Investment Fund

Arix Bioscience

Solasta Ventures

F-Prime Capital

Takeda Ventures

SymBiosis

Alexandria Venture Investments

Fred Hutchinson Cancer Center

Qatar Investment Authority

Catalio Capital Management

Mirae Asset Financial Group

Cormorant Asset Management

Viking Global Investors

Genomic Medicines

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →